Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Par Health, USA LLC

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Par Health, USA LLC with status Current. The shortage was first posted on Jun 16, 2022. Reported reason: Other

Shortage details

Status
Current
Company
Par Health, USA LLC
Package NDC
42023-240-01
Dosage Form
Injection
Presentation
Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)
Initial Posting
Jun 16, 2022

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.